Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use

被引：9

作者：

Lesieur, Auriane ^{[1
]}

Thomas, Xavier ^{[2
]}

Nibourel, Olivier ^{[1
,3
]}

Boissel, Nicolas ^{[4
]}

Fenwarth, Laurene ^{[1
,3
]}

De Botton, Stephane ^{[5
]}

Fournier, Elise ^{[1
,3
]}

Celli-Lebras, Karine ^{[4
]}

Raffoux, Emmanuel ^{[4
]}

Recher, Christian ^{[6
]}

Lambert, Juliette ^{[7
]}

Berthon, Celine ^{[3
,8
]}

Pigneux, Arnaud ^{[9
]}

Itzykson, Raphael ^{[4
]}

Turlure, Pascal ^{[10
]}

Pautas, Cecile ^{[11
]}

Vargaftig, Jacques ^{[12
]}

Preudhomme, Claude ^{[1
,3
]}

Dombret, Herve ^{[4
]}

Duployez, Nicolas ^{[1
,3
]}

机构：

[1] CHU Lille, Lab Hematol, Lille, France

[2] Lyon Sud Univ Hosp, Hosp Civils Lyon, Dept Hematol, Lyon, France

[3] Univ Lille, Canther Canc Heterogene Plast & Resistance Therap, Inst Rech Canc Lille, CHU Lille,Inserm,CNRS,UMR9020,UMR S 1277, Lille, France

[4] Univ Paris, St Louis Res Inst, St Louis Hosp, Dept Hematol,AP HP, Paris, France

[5] Gustave Roussy Inst, Dept Hematol, Villejuif, France

[6] Toulouse Canc Univ Inst, Dept Hematol, Toulouse, France

[7] CH Versailles, Dept Hematol, Le Chesnay, France

[8] CHU Lille, Dept Clin Hematol, Lille, France

[9] Bordeaux Haut Leveque Univ Hosp, Dept Hematol, Pessac, France

[10] Univ Limoges, CHU Limoges, Dept Hematol, Limoges, France

[11] Henri Mondor Hosp, AP HP, Dept Hematol, Creteil, France

[12] Rene Huguenin Hosp, Curie Hosp, St Cloud, France

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 06期

关键词：

NUCLEOPHOSMIN; AML;

D O I：

10.3324/haematol.2020.260133

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1767 / 1769

页数：3

共 50 条

[21] Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations
Thol, Felicitas
Koelking, Britta
Damm, Frederik
Reinhardt, Katarina
Klusmann, Jan-Henning
Reinhardt, Dirk
von Neuhoff, Nils
Brugman, Martijn H.
Schlegelberger, Brigitte
Suerbaum, Sebastian
Krauter, Juergen
Ganser, Arnold
Heuser, Michael
GENES CHROMOSOMES & CANCER, 2012, 51 (07): : 689 - 695
[22] Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor
Papadaki, Christina
Dufour, Annika
Seibl, Marlene
Schneider, Stephanie
Bohlander, Stefan K.
Zellmeier, Evelyn
Mellert, Gudrun
Hiddemann, Wolfgang
Spiekermann, Karsten
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (04) : 517 - 523
[23] Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)
Kroenke, Jan
Schlenk, Richard
Jensen, Kai-Ole
Eiwen, Karina
Habdank, Marianne
Spaeth, Daniela
Krauter, Juergen
Ganser, Arnold
Doehner, Hartmut
Doehner, Konstanze
BLOOD, 2008, 112 (11) : 260 - 260
[24] Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia
Suzuki, T
Kiyoi, H
Ozeki, K
Tomita, A
Yamaji, S
Suzuki, R
Kodera, Y
Miyawaki, S
Asou, N
Kuriyama, K
Yagasaki, F
Shimazaki, C
Akiyama, H
Nishimura, M
Motoji, T
Shinagawa, K
Takeshita, A
Ueda, R
Kinoshita, T
Emi, N
Naoe, T
BLOOD, 2005, 106 (08) : 2854 - 2861
[25] Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia
Christopher, Mary R.
Nawas, Mariam T.
Reagan, John L.
BONE MARROW TRANSPLANTATION, 2025, 60 (02) : 135 - 143
[26] A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations
D Dvorakova
M Lengerova
J Pospisilova
I Palasek
J Mayer
Leukemia, 2009, 23 : 793 - 796
[27] A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations
Dvorakova, D.
Lengerova, M.
Pospisilova, J.
Palasek, I.
Mayer, J.
LEUKEMIA, 2009, 23 (04) : 793 - 796
[28] Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene
Jeziskova, Ivana
Razga, Filip
Toskova, Martina
Dvorakova, Dana
Timilsina, Shira
Mayer, Jiri
Racil, Zdenek
LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 867 - 870
[29] Evaluation of NPM1 Drop Off Droplet Digital PCR Assay for Minimal Residual Disease Detection in Acute Myeloid Leukemia Patients
Mehrotra, M.
Guan, M.
Manning, C.
Dupuy, A.
Barbari, S.
Houldsworth, J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S158 - S158
[30] Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives
Forghieri, Fabio
Comoli, Patrizia
Marasca, Roberto
Potenza, Leonardo
Luppi, Mario
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)

← 1 2 3 4 5 →